Prelude Capital Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.4K | Buy |
+10,867
| New | +$31.4K | ﹤0.01% | 960 |
|
|
2023
Q3 | – | Sell |
-19,013
| Closed | -$59.5K | – | 1125 |
|
|
2023
Q2 | $59.5K | Buy |
19,013
+6,313
| +50% | +$19.8K | ﹤0.01% | 847 |
|
|
2023
Q1 | $57.5K | Buy |
+12,700
| New | +$57.5K | ﹤0.01% | 898 |
|
|
2018
Q2 | – | Sell |
-258
| Closed | -$23K | – | 1519 |
|
|
2018
Q1 | $23K | Buy |
+258
| New | +$23K | ﹤0.01% | 1090 |
|
|
2017
Q4 | – | Sell |
-108
| Closed | -$5K | – | 1423 |
|
|
2017
Q3 | $5K | Buy |
+108
| New | +$5K | ﹤0.01% | 1374 |
|
|
2017
Q2 | – | Sell |
-1,742
| Closed | -$97K | – | 1626 |
|
|
2017
Q1 | $97K | Buy |
1,742
+1,700
| +4,048% | +$94.7K | 0.01% | 744 |
|
|
2016
Q4 | $2K | Sell |
42
-58
| -58% | -$2.76K | ﹤0.01% | 1441 |
|
|
2016
Q3 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 1424 |
|